Repligen Corporation (RGN)
Munich
Real-time Data
06:00 AM
Day's Range
167.9052 wk Range
89.11Overview - RGN - Repligen Corporation
Key Statistics
Valuation
Enterprise Value
123.92M
P/E (Trailing)
‪191.14‬
PEG Ratio
‪-2.92‬
Price / Book
‪4.44‬
EV / EBITDA
‪0.88‬
Profitability
Gross Margin
‪53.90%‬
Profit Margin
‪52.31%‬
Operating Margin
‪11.36%‬
Return on Assets
‪1.65%‬
Return on Equity
‪2.32%‬
Ownership
Shares Outstanding
56.42M
Price stats
50-Day Avg
‪140.92‬
200-Day Avg
‪121.71‬
Peers - RGN - Repligen Corporation
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on Munich.
- RGNMunichRepligen Corporation+35.75%52-week change191.15P/E (Trailing)‪52.31%‬Profit Margin
- 6L8MunichPulse Biosciences Inc+67.25%52-week change-42.41P/E (Trailing)‪-54.00%‬Profit Margin
- TENMunichTecan Group AG+33.32%52-week change-28.33P/E (Trailing)‪35.22%‬Profit Margin
- WPSMunichWest Pharmaceutical Services, Inc.+32.80%52-week change48.07P/E (Trailing)‪35.91%‬Profit Margin
- 1MDMunichModern Dental Group Ltd.+32.20%52-week change1.39P/E (Trailing)‪55.79%‬Profit Margin
- UG2MunichAngioDynamics Inc.+27.94%52-week change-15.45P/E (Trailing)‪54.62%‬Profit Margin
- 6XTMunichAsahi Intecc Co., Ltd.+23.66%52-week change—P/E (Trailing)‪67.68%‬Profit Margin
Profile Summary - RGN - Repligen Corporation
About
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems used in the manufacture of biologic drugs. Repligen Corporation’s portfolio supports both upstream and downstream workflows across filtration, fluid management, chromatography, process…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
